Long-Term NIV in COPD – Who and When? - European Medical Journal
×

Browse

Long-Term NIV in COPD – Who and When?

| Download as | PDF
Chairpeople:
Peter Wijkstra,1 Wolfram Windisch2
Speakers:
Thomas Köhnlein,3 Christine Cheval4
Disclosure:

Peter Wijkstra has received open research grants for his hospital and personal speaking fees from companies dealing with mechanical ventilation, Respironic/Philips, ResMed, VIVISOL, Emdamed, Mediq Tefa, and Air Liquide. Wolfram Windisch has received open research grants for his hospital and personal speaking fees from companies dealing with mechanical ventilation. Thomas Köhnlein has received grants and lecture fees from Deutsche Lungenstiftung, ResMed, Tyco, Weinmann, and Heinen und Löwenstein. Christine Cheval has no competing interests to disclose. Stefano Nava has no competing interests to disclose. Nick Hart has received grants and lecture fees from ResMed, Philips, and Fisher & Paykel. Jean-Louis Pépin has received personal fees from ResMed, Philips, and Fisher & Paykel for lectures during congress symposia, and unrestricted grants from ResMed, Philips, and AGIRadom for conducting clinical studies.

Acknowledgements:

Writing assistance was provided by Dr Tom Priddle, ApotheCom.

Support:

Medical writing assistance was funded by ResMed. The views and opinions expressed are those of the authors as expressed during the symposium and not necessarily those of ResMed.

Citation
EMJ Resp. ;3[2]:71-77.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Meeting Summary

Dr Wijkstra opened this symposium on long-term non-invasive ventilation (NIV) in the treatment of chronic obstructive pulmonary disease (COPD). Dr Köhnlein presented data from a recent randomised controlled trial (RCT) of NIV for the treatment of severe stable COPD.1 Dr Cheval discussed the use of telemonitoring
in French patients with COPD. The meeting concluded with a round-table discussion on the international practice of home mechanical ventilation (HMV) for COPD, moderated by Dr Wijkstra and Prof Windisch with contributions from Dr Köhnlein, Dr Nava, Dr Hart, and Prof Pépin.

Receive our free quarterly newsletters and your choice of journal publication alerts, straight to your inbox.

Join our mailing list

Round-table discussion panel

Stefano Nava,5 Nick Hart,6 Jean-Louis Pépin7,8

Please view the full content in the pdf above.